The synthesis of 4-deazaformycin A

Journal of Organic Chemistry

Volumn 68, Issue 16, 2003, Pages 6466-6469

  Kourafalos, Vassilios N ^a   Marakos, Panagiotis ^a   Pouli, Nicole ^a   Townsend, Leroy B ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONDENSATION; HYDROGENATION; SYNTHESIS (CHEMICAL);

IONIC HYDROGENATION;

ORGANIC COMPOUNDS;

4 DEAZAFORMYCIN A; 7 AMINO 3 (BETA DEXTRO RIBOFURANOSYL)PYRAZOLO[3,4 C]PYRIDINE; FORMYCIN; FORMYCIN B; PICOLINE; PICOLINE DERIVATIVE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROGENATION; POLYMERIZATION; RING CLOSING METATHESIS;

CHROMATOGRAPHY, THIN LAYER; FORMYCINS; FURANS; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; PYRAZOLES; PYRIDINES; STEREOISOMERISM;

EID: 0041573419     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo026715x     Document Type: Article

References (26)

1. (a) Elion, G. B.; Furman, P. A.; Fyfe, G. A.; de Miranda, P.; Beauchamp, L.; Schaeffer, H. J. Proc. Natl. Acad. Sci. U.S.A. 1977, 74, 5716-5720.
2. (b) Moore, R. D.; Hidalgo, J.; Sugland, B. W.; Chaisson, R. E. N. Engl. J. Med. 1991, 324, 1412-1416.
3. (c) Yarchoan, R.; Pluda, J. M.; Thomas, R. V.; Mitsuya, H.; Brouwers, P.; Wyvill, K. M.; Hartman, N.; Johns, D. G.; Broder, S. Lancet 1990, 336, 526-529.
4. For a review of the chemistry and biology of C-nucleosides, see: Watanabe, K. A. The Chemistry of C-Nucleosides. In Chemistry of Nucleosides and Nucleotides; Townsend, L. B., Ed; Plenum Press: New York, 1994; Vol. 3, pp 421-535.
5. (a) Von Krosigk, U.; Benner, S. A. J. Am. Chem. Soc. 1995, 117, 5261-5362.
6. (b) Matulic-Adamic, J.; Beigelman, L.; Portmann, S.; Egli, M.; Usman, N. J. Org. Chem. 1996, 61, 3909-3911.
7. (c) Hilbrand, S.; Blaser, A.; Parel, P. S.; Leumann, C. J. J. Am. Chem. Soc. 1997, 119, 5499-5511.
8. (a) Srivastava, P. C.; Pickering, M. V.; Allen, L. B.; Streeter, D. G.; Campbell, M. T.; Witowski, J. T.; Sidwell, R. W.; Robins, R. K. J. Med. Chem. 1977, 20, 256-262.
9. (b) Orozco, M.; Canela, E. I.; Franco, R. Mol. Pharmacol. 1989, 35, 257-264.
10. Robins, R. K.; Townsend, L. B.; Cassidy, F.; Gerster, F. G.; Lewis, A. F.; Miller, R. L. J. Heterocycl. Chem. 1966, 3, 110-114.
11. Hori, M.; Ito, E.; Takita, T.; Koyama, G.; Takeuchi, T.; Umezawa, H. J. Antibiot. Ser. A 1964, 17, 96-99.
12. Buchanan, J. G. Fortschr. Chem. Org. Natr. 1983, 44, 243-312.
13. (a) Gudmundsson, K. S.; Drach, J. C.; Townsend, L. B. J. Org. Chem 1997, 62, 3453-3459.
14. (b) Walker, J. A., II; Liu, W.; Wise, D. S.; Drach, J. C.; Townsend, L. B. J. Med. Chem. 1998, 41, 1236-1241.
15. (c) Liu, W.; Wise, D. S.; Townsend, L. B. J. Org. Chem 2001, 66, 4783-4786.
16. (d) Kourafalos, V. N.; Marakos, P.; Pouli, N.; Townsend, L. B. Synlett 2002, 1479-1482.
17. Kourafalos, V. N.; Marakos, P.; Pouli, N.; Terzis, A.; Townsend, L. B. Heterocycles 2002, 57, 2335-2343.
18. Ihle, N. C.; Krause, A. J. Org. Chem. 1996, 61, 4810-4811.
19. (a) Cousineau, T. J.; Secrist, J. A., III J. Org. Chem. 1979, 44, 4, 4351-4358.
20. (b) Timpe, W.; Dax, K.; Wolf, N.; Weidmann, H. Carbohydr. Res. 1975, 69, 51-60.
21. It should be pointed out that for hemiacetals 5 the prefix α refers to the position of the glycosidic OH group relative to the configuration at the reference C-atom (C-4′ in 5; i.e., the methylpyridinyl moiety is in the β-position). For C-glycosides (no glycosidic OH present), the prefix α-D refers to the alkyl (or aryl) position relative to the reference C-atom.
22. (a) Dondoni, A.; Scherrmann, M. C. J. Org. Chem. 1994, 59, 6404-6412.
23. (b) Piccirilli, J. A.; Krauch, T.; MacPherson, L. J.; Benner, S. A. Helv. Chim. Acta 1991, 74, 397-406.
24. (a) Posner, G. H.; Switzer, C. J. Am. Chem. Soc. 1986, 108, 1239-1244.
25. (b) Kurzanov, D. N.; Parnes, Z. N.; Loim, N. M. Synthesis 1974, 633-651.
26. Marakos, P.; Pouli, N.; Wise, D. S.; Townsend, L. B. Synlett 1997, 561-562.